InvestSMART

Mach7 Technologies Limited (ASX:M7T)

ALERT: Price-sensitive ASX Announcement for M7T
Current share price for M7T : $0.300 0.015 (5.26%)+
Announcement
Release
20 May 2026 9:41AM
Price at Release
$0.285
Full Release
download
Summary
Mach7 Technologies Limited has announced a new contract with American Radiologist Network Inc. (AMRADNET), a US-based teleradiology provider, for a 5-year subscription licence for its eUnity Viewer. This agreement, valued initially at A$1.7 million, aims to handle a minimum of 0.675 million studies per year, potentially exceeding 1 million studies within the contract term. The contract, effective from 20 May 2026, showcases a significant reduction in Mach7's sales cycle and time to first productive use, reflecting the company's ongoing commercial transformation and restructuring efforts. This partnership is expected to expand AMRADNET's capacity in the US healthcare market for high-volume imaging environments.
Key Points
  • American Radiologist Network Inc. (AMRADNET) signs a 5-year annual subscription licence for eUnity Viewer.
  • The initial contract value is A$1.7 million based on 0.675 million studies annually.
  • Projected volumes may exceed 1 million studies over the 5-year period.
  • Sales cycle and first productive use (FPU) timeframe significantly reduced.
  • Mach7 aims to support AMRADNET's expansion in clinical reach and imaging volume.
  • Contract effective from 20 May 2026, with FPU expected within 45 days.
  • Mach7 is undergoing commercial transformation with restructuring of sales and services teams.
  • Mach7 Technologies Limited provides enterprise imaging solutions enabling secure diagnostic imaging management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.